AI-Driven miRNA Target Identification Combined with Nanocarrier-Based Therapy Enhances Amastigote Clearance in Canine Visceral Leishmaniasis: An Integrated In Silico and Ex Vivo Study
This study demonstrates that integrating AI-driven prioritization of host miRNAs with miltefosine-loaded PLGA nanoparticles significantly enhances the clearance of *Leishmania infantum* in primary canine macrophages by modulating immune responses, providing a proof-of-concept for this combined therapeutic approach against canine visceral leishmaniasis.